Related to Studies Show PGE₂ Receptor EP4 Exerts Protective Effects in Stroke that Can Be Boosted Pharmacologically

• Japan Sanctions BI’s Dabigatran for Preventing Stroke or Venous Embolism in AF Patients
  
• Moleculence to Use Pronota's Platforms to Find Biomarkers for Stroke
  
• Gamma Partners with Health Diagnostic Lab to Develop Risk Assay for Heart Attack and Stroke
  
• Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program
  
• NeurOp Wins $3M from NIH to Progress NMDA Antagonist for Preventing Stroke
  
• EC Approves BI’s Pradaxa for Preventing Stroke in Atrial Fibrillation Patients
  
• Astellas Ditches Development of Oral Direct Factor Xa Inhibitor Darexaban
  
• NeuroVive and to-BBB Get €1M Boost to Stroke Therapy Collaboration
  
• FDA Green-Lights Janssen's Anticoagulant for Reducing Stroke/Embolism in Nonvalvular AF Patients
  
• Proteome Sciences to Carry Out Biomarker Analyses for €11M EU-Funded Stroke Hypothermia Trial
  
• BMS, Pfizer Fail to Win FDA Sanction for Stroke Prevention Drug
  
• Biomarker Indicates Suitability of Stroke Therapy
  
• Phase III Results Promising for Diabetes, Gaucher, Atrial Fibrillation Drugs
  
• Flu Shot Prevents Heart Attacks and Stroke
  
• FDA Finally Approves Pfizer & BMS' Stroke Prevention Drug
  
• Two Genetic Variants Tied to Increased Stroke Risk
  
• Researchers Discover Potential Mechanism for Preventing Cell Death After Stroke
  
• DSP Nabs U.S. and Canadian Marketing Option to SanBio’s Phase I Cell Therapy
  
• Nonfasting Triglyceride Levels Linked to Ischemic Stroke Risk
  
• Studies Show Natural Protein May Provide Benefits Against Stroke up to 12 Hours After Onset